STIM

Neuronetics (STIM)

Neuronetics Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:STIM

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/12/20	07 : 54	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:STIM	Neuronetics Inc
2024/12/20	07 : 00	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:STIM	Neuronetics Inc
2024/12/20	07 : 00	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:STIM	Neuronetics Inc
2024/12/19	06 : 30	GlobeNewswire Inc.	Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:STIM	Neuronetics Inc
2024/12/18	11 : 15	Edgar (US Regulatory)	Form SC 13D - General Statement of Acquisition of Beneficial Ownership	NASDAQ:STIM	Neuronetics Inc
2024/12/17	06 : 30	GlobeNewswire Inc.	Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:STIM	Neuronetics Inc
2024/12/13	07 : 00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:STIM	Neuronetics Inc
2024/12/13	07 : 00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:STIM	Neuronetics Inc
2024/12/13	07 : 00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:STIM	Neuronetics Inc
2024/12/11	06 : 45	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:STIM	Neuronetics Inc
2024/12/11	00 : 00	GlobeNewswire Inc.	Neuronetics and Greenbrook TMS Announce Closing of Transaction	NASDAQ:STIM	Neuronetics Inc
2024/11/20	22 : 30	GlobeNewswire Inc.	Neuronetics to Present at the Piper Sandler 36th Annual Healthcare Conference	NASDAQ:STIM	Neuronetics Inc
2024/11/15	04 : 32	Edgar (US Regulatory)	Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors	NASDAQ:STIM	Neuronetics Inc
2024/11/15	01 : 32	Edgar (US Regulatory)	Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]	NASDAQ:STIM	Neuronetics Inc
2024/11/15	01 : 17	Edgar (US Regulatory)	Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]	NASDAQ:STIM	Neuronetics Inc
2024/11/13	20 : 44	Edgar (US Regulatory)	Form 8-K/A - Current report: [Amend]	NASDAQ:STIM	Neuronetics Inc
2024/11/13	08 : 45	GlobeNewswire Inc.	CORRECTION—Neuronetics Reports Record Third Quarter 2024 Financial and Operating Results	NASDAQ:STIM	Neuronetics Inc
2024/11/13	06 : 30	GlobeNewswire Inc.	Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:STIM	Neuronetics Inc
2024/11/12	21 : 31	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:STIM	Neuronetics Inc
2024/11/12	21 : 10	GlobeNewswire Inc.	Neuronetics Reports Record Third Quarter 2024 Financial and Operating Results	NASDAQ:STIM	Neuronetics Inc
2024/11/12	21 : 03	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:STIM	Neuronetics Inc
2024/11/12	21 : 01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:STIM	Neuronetics Inc
2024/11/12	21 : 01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:STIM	Neuronetics Inc
2024/11/02	06 : 20	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:STIM	Neuronetics Inc
2024/11/02	06 : 18	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:STIM	Neuronetics Inc
2024/10/30	05 : 30	GlobeNewswire Inc.	Neuronetics to Report Third Quarter 2024 Financial and Operating Results and Host Conference Call	NASDAQ:STIM	Neuronetics Inc
2024/10/14	21 : 31	GlobeNewswire Inc.	NeuroStar® Oral Presentation at AACAP 2024 Highlights Largest Study Evaluating TMS Efficacy in Adolescents with Depression	NASDAQ:STIM	Neuronetics Inc
2024/10/11	06 : 05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:STIM	Neuronetics Inc
2024/10/11	06 : 05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:STIM	Neuronetics Inc
2024/10/10	05 : 30	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:STIM	Neuronetics Inc